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The ﬁrst enantioselective synthesis of ()-paeonilide is reported.
Starting from inexpensive furan-3-carboxylic acid the targeted
monoterpene was obtained in 12 steps via an asymmetric
cyclopropanation-lactonization cascade and a stereoselective
side chain insertion at an acetal-like position.
Natural products of herbal origin had an indisputable impact
on modern medicinal chemistry and still break ground for new
drugs. Paeonia root bark containing prescriptions like the
multiherbal formula GuiZhiFuLing-Wan are employed in
China, Japan and Korea to alleviate the syndromes of blood
stasis and stiﬀness of abdominal muscles.1–3 (+)-Paeonilide
(+)-(1), a monoterpenoid isolated from Paeonia delavayi,4 is a
substructure of the privileged class of ginkgolides. In bioassays it
showed selective inhibition of the platelet aggregation induced by
PAF (platelet activating factor) with an IC50 value of 8 mg mL
1,
but importantly, no eﬀect on the platelet aggregation induced by
adenoside diphosphate (ADP) or arachidonic acid (AA).4
Two racemic5,6 and one ex-chiral pool7 synthesis of paeonilide
have been reported to date, the latter achieved the synthesis of
(+)-paeonilide (+)-(1) starting from chiral ()-carvone. We report
here a strategy that allows facile access to either enantiomer of
paeonilide. Since only the (+)-enantiomer was tested in bioassays
until now, we opted to demonstrate our strategy with the synthesis
of its antipode to gain further insight into the biological activity of 1.
The three key steps of our strategy are the synthesis of 4 by an
enantioselective cyclopropanation of 6 derived from commercially
available furan-3-carboxylic acid (5) (Scheme 1 and Table 1),
its transformation to the core structure 3 by donor–acceptor
substituted cyclopropane ring-opening/intramolecular lactonization
cascade of 4, and synthesis of 2 by introducing an allyl side
chain at the acetal-like position in 3.
We had previously developed the cyclopropanation of
furan-2-carboxylic acid esters with ethyl diazoacetate8 as a facile
entry into various g-butyrolactone containing natural products,9
which proceeds in the presence of copper(I)-bis(oxazoline)
CuOTf8a in 94% ee. The asymmetric cyclopropanation of the
corresponding 3-methylester 6 turned out to be more challenging,
most likely due to the fact that the ester group in the 3-position
is too far away to eﬀectively interact with the catalyst, as depicted
in the transition state 9 that rationalizes the asymmetric pathway
Scheme 1 Retrosynthetic analysis of ()-paeonilide ()-(1).
Table 1 Asymmetric cyclopropanation of 6
Entry Diazoester R Ligand Yield [%] % ee
1 Et 7a 27 74
2 tBu 7 38 65
3 Et 8aa 22 74
4 Et 8b 31 83
5 tBu 8b 38b 83
6 tBu 8c 34 19
a Ref. 8b. b 53% based on recovered starting material.
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of the process. Nevertheless, 4 could be obtained in 83% ee
using CuOTf8b (Table 1, entries 4 and 5), being surprisingly
more selective than the sterically more bulky catalysts CuOTf
8a (entry 3) or CuOTf8c (entry 6). In order to avoid the
competing twofold cyclopropanation, it turned out to be
advantageous to run the reaction only to about 50% conversion,
nevertheless, 4b could be readily produced on a 20 g scale.
Unfortunately, all eﬀorts to enhance the enantiomeric excess
via recrystallization at this stage failed due to the excellent
solubility of 4b in most solvents.
In order to transform the hydroxycyclopropane ester unit
into the desired lactone, it was necessary to ﬁrst reduce the
double bond in 4b to avoid rearomatization to a furan during the
ring opening of the donor–acceptor-substituted cyclopropane.
However, direct hydrogenation of 4b under a variety of conditions
only proceeded in low yields.
In contrast, the carboxylic acid 10 being obtained by
selective hydrolysis of 4b allowed the quantitative transformation
to 11, in which the carboxylic acid group is placed selectively
on the concave face of the bicycle. Acid induced cyclopropane
ring-opening/lactonization10 proceeded smoothly to 12, establishing
the core structure of paeonilide in which the relative stereochemistry
of the acid substituent with respect to the ring junctions needs to be
corrected. Treatment of 12 with pyridine gave rise to 3, exploiting
the higher stability of bicyclo[3.3.0] frameworks that orient larger
groups on its convex face. Notably, the stereocenters on the ring
junctions undergo epimerization as proved by X-ray-structure
analysis of 12 and the ammonium salt obtained from 3 and
(R)-1-(4-chlorophenyl)ethylamine (Scheme 3), being also in
agreement with epimerization studies of similar furolactones.11
The ﬁnal challenge towards paeonilide (1) consisted of the
introduction of the side chain at the acetal-like position of 3,
thus requiring the creation of a quaternary stereocenter to
arrive at 15 (Scheme 4).
All attempts to realize this goal by a direct C–H insertion of
a carbene following leads known in the literature12 for achieving
such transformations at the 2-position of THF or at the acetal
carbon of 1,3-dioxolanes with diazoesters in the presence of copper
or rhodium catalysts failed. As an alternative, lactone opening
followed by oxidation to 13 was envisioned, which should allow
the addition of nucleophiles to 16 followed by relactonization
to give the desired 15.
In practice (Scheme 2), lactone 3 was treated with Jones-
reagent, simultaneously opening the lactone and oxidizing the
hemi-acetale to the a,b-dicarboxy-g-lactone 13 in very good
yield. Addition of allylmagnesiumbromide followed by acidic
workup gave rise to 2 in which an allyl group was installed
stereoselectively into the bicyclic framework.
Reduction of the carboxylic acid at this stage to create the
required alcohol functionality aﬀorded only very low yields.
Oxidizing the allyl substituent with Jones-reagent combined
with catalytic amounts of mercury(II)-acetate led to 14, while
the oxidation under Wacker conditions aﬀorded the desired
Scheme 2 Synthesis of ()-paeonilide ()-(1).
Scheme 3 Base induced isomerization of 12 to 3.
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product as well but was accompanied by several by-products.
Finally, a reduction–benzoylation–oxidation sequence of 14 via
the corresponding diol selectively allowed functionalization of
the primary alcohol. Final oxidation of the secondary alcohol
with Dess–Martin periodinane (DMP) yielded ()-paeonilide
()-(1) in 83% ee corresponding to the enantioselectivity
achieved in the cyclopropanation of 6. All spectroscopic data
were in accordance to literature data, furthermore, the structure
of ()-1 was conﬁrmed by X-ray crystallography (Fig. 1).
The antagonistic activity of ()-1 against the PAF receptor
was found to be negligible compared to the naturally occurring
enantiomer (+)-1: the thrombocyte aggregation was inhibited
only by 20% at a concentration of 30 mg mL1 (94 mM) of
()-1 (cf. (+)-1 (IC50 = 8 mg mL1, 25 mM)). Presumably, the
antagonism observed is caused by the impurity of the eutomeric
(+)-1 in the measured sample.
In conclusion we reported the ﬁrst enantioselective synthesis
of the natural product ()-paeonilide ()-(1), which was
synthesized in 12 steps and an overall yield of 4.4% (7.7%
brsm) starting from 3-furoic acid (5). Biological tests implicate
the inactivity of ()-1 against the PAF receptor, giving further
credit to the unique and selective activity of naturally occur-
ring (+)-paeonilide (+)-(1).
We thank Dr Egon Koch, Schwalbe GmbH&CoKG, for
carrying out biological testing on ()-1 as well as Dr Manfred
Zabel, Sabine Stempfhuber and Dr Michael Bodensteiner,
Department of Crystallography, University of Regensburg,
for X-ray structure analyses.
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Scheme 4 Synthetic strategy for the introduction of side chains R at
the acetal-like position of furolactones.
Fig. 1 X-Ray structure of ()-paeonilide ()-(1).
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